What is Lisata Therapeutics, Inc (LSTA)?
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for the treatment of cancer. The company’s research and development efforts concentrate on targeted therapies that address specific molecular pathways implicated in oncology. Lisata Therapeutics aims to advance its pipeline through clinical trials designed to evaluate safety and efficacy in various cancer indications. The company’s approach involves leveraging scientific insights and innovative drug design to create treatments that may offer improved outcomes for patients with unmet medical needs. Lisata Therapeutics collaborates with academic institutions and research organizations to support its development programs. Its operations are centered on advancing clinical-stage assets toward regulatory approval and potential commercialization within the oncology therapeutic area.
Lisata Therapeutics, Inc Stock Price Today: Live Overview
The price today is shaped by current market dynamics, with Lisata Therapeutics, Inc at a trading level of $5.04. The price range for the day extends from $4.98 to $4.99, marking a change of -0.2004%.
FAQ: Lisata Therapeutics, Inc (LSTA)
What is the current price of LSTA stock?
Lisata Therapeutics, Inc is trading at $5.04.
Does LSTA pay dividends?
Lisata Therapeutics, Inc does not currently pay dividends.
Does LSTA have a formal corporate presence or regional headquarters in the UAE?
Lisata Therapeutics, Inc does not have an official office or subsidiary in the UAE and operates via partners.
What is LSTA best known for?
Lisata Therapeutics, Inc is most famous for developing novel oncology therapeutics.
What assets are typically shown together with LSTA?
Commonly shown alongside LSTA: Agenus, Compugen Ltd., Evotec SE
Latest shares articles



